RainDance Unveils Details of ThunderBolts Cancer Panel; Sees Market Advantage over TruSeq, AmpliSeq | GenomeWeb

RainDance Technologies plans to launch a somatic cancer sequencing panel this spring that focuses on key areas of about 50 genes that are often mutated in cancer. It will likely compete with similar panels offered by Illumina and Ion Torrent, promising advantages in terms of DNA input requirements, ease of workflow, and overall cost per sample.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.